Report cover image

Global Anti-Tumor Drugs Databank Market Report

Publisher Magna Intelligence
Published Apr 26, 2024
Length 100 Pages
SKU # MAIN18749750

Description

Global Anti-Tumor Drugs Databank Market Report


The Anti-Tumor Drugs market was valued at $451,922.8 Million in 2020, and is projected to reach $976,438.3 Million by 2029 growing at a CAGR of 8.98% from 2021 to 2029. Chemotherapy segment is expected to be the highest contributor to this market, with $234,295.8 Million in 2020, and is anticipated to reach $496,893.9 Million by 2029, registering a CAGR of 8.76%. Hormonal Therapy segment is anticipated to reach $212,183.7 Million by 2029 with the highest CAGR of 10.19%. Chemotherapy and Immunotherapy segments collectively expected to account for about 73.3% share of the Anti-Tumor Drugs market in 2020, with the former constituting around 51.8% share. Hormonal Therapy and Immunotherapy segments are expected to witness significant growth rates at a CAGR of 10.19% and 9.06% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 41.1% in the overall Anti-Tumor Drugs market in 2020, and is anticipated to reach 43.3% by 2029.

Table of Contents

100 Pages
1. Global Anti-Tumor Drugs Market, By Type
1.1. Overview
1.2. Chemotherapy
1.2.1 Chemotherapy Market, By Region
1.2.1.1 North America Chemotherapy Market, By Country
1.2.1.2 Europe Chemotherapy Market, By Country
1.2.1.3 Asia-Pacific Chemotherapy Market, By Country
1.2.1.4 Rest of World Chemotherapy Market, By Country
1.3. Hormonal Therapy
1.3.1 Hormonal Therapy Market, By Region
1.3.1.1 North America Hormonal Therapy Market, By Country
1.3.1.2 Europe Hormonal Therapy Market, By Country
1.3.1.3 Asia-Pacific Hormonal Therapy Market, By Country
1.3.1.4 Rest of World Hormonal Therapy Market, By Country
1.4. Immunotherapy
1.4.1 Immunotherapy Market, By Region
1.4.1.1 North America Immunotherapy Market, By Country
1.4.1.2 Europe Immunotherapy Market, By Country
1.4.1.3 Asia-Pacific Immunotherapy Market, By Country
1.4.1.4 Rest of World Immunotherapy Market, By Country
1.5. Other Types
1.5.1 Other Types Market, By Region
1.5.1.1 North America Other Types Market, By Country
1.5.1.2 Europe Other Types Market, By Country
1.5.1.3 Asia-Pacific Other Types Market, By Country
1.5.1.4 Rest of World Other Types Market, By Country
2. Global Anti-Tumor Drugs Market, By Application
2.1. Overview
2.2. Lung Cancer
2.2.1 Lung Cancer Market, By Region
2.2.1.1 North America Lung Cancer Market, By Country
2.2.1.2 Europe Lung Cancer Market, By Country
2.2.1.3 Asia-Pacific Lung Cancer Market, By Country
2.2.1.4 Rest of World Lung Cancer Market, By Country
2.3. Other Applications
2.3.1 Other Applications Market, By Region
2.3.1.1 North America Other Applications Market, By Country
2.3.1.2 Europe Other Applications Market, By Country
2.3.1.3 Asia-Pacific Other Applications Market, By Country
2.3.1.4 Rest of World Other Applications Market, By Country
2.4. Stomach Cancer
2.4.1 Stomach Cancer Market, By Region
2.4.1.1 North America Stomach Cancer Market, By Country
2.4.1.2 Europe Stomach Cancer Market, By Country
2.4.1.3 Asia-Pacific Stomach Cancer Market, By Country
2.4.1.4 Rest of World Stomach Cancer Market, By Country
2.5. Breast Cancer
2.5.1 Breast Cancer Market, By Region
2.5.1.1 North America Breast Cancer Market, By Country
2.5.1.2 Europe Breast Cancer Market, By Country
2.5.1.3 Asia-Pacific Breast Cancer Market, By Country
2.5.1.4 Rest of World Breast Cancer Market, By Country
3. Global Anti-Tumor Drugs Market, By Region
3.1. Overview
3.2. North America
3.2.1 North America Anti-Tumor Drugs Market, By Type
3.2.2 North America Anti-Tumor Drugs Market, By Application
3.2.3 North America Anti-Tumor Drugs Market, By Country
3.2.3.1 U.S.
3.2.3.1.1 U.S. Anti-Tumor Drugs Market, By Type
3.2.3.1.2 U.S. Anti-Tumor Drugs Market, By Application
3.2.3.2 Canada
3.2.3.2.1 Canada Anti-Tumor Drugs Market, By Type
3.2.3.2.2 Canada Anti-Tumor Drugs Market, By Application
3.2.3.3 Mexico
3.2.3.3.1 Mexico Anti-Tumor Drugs Market, By Type
3.2.3.3.2 Mexico Anti-Tumor Drugs Market, By Application
3.3. Europe
3.3.1 Europe Anti-Tumor Drugs Market, By Type
3.3.2 Europe Anti-Tumor Drugs Market, By Application
3.3.3 Europe Anti-Tumor Drugs Market, By Country
3.3.3.1 Germany
3.3.3.1.1 Germany Anti-Tumor Drugs Market, By Type
3.3.3.1.2 Germany Anti-Tumor Drugs Market, By Application
3.3.3.2 France
3.3.3.2.1 France Anti-Tumor Drugs Market, By Type
3.3.3.2.2 France Anti-Tumor Drugs Market, By Application
3.3.3.3 U.K.
3.3.3.3.1 U.K. Anti-Tumor Drugs Market, By Type
3.3.3.3.2 U.K. Anti-Tumor Drugs Market, By Application
3.3.3.4 Italy
3.3.3.4.1 Italy Anti-Tumor Drugs Market, By Type
3.3.3.4.2 Italy Anti-Tumor Drugs Market, By Application
3.3.3.5 Spain
3.3.3.5.1 Spain Anti-Tumor Drugs Market, By Type
3.3.3.5.2 Spain Anti-Tumor Drugs Market, By Application
3.3.3.6 Rest of Europe
3.3.3.6.1 Rest of Europe Anti-Tumor Drugs Market, By Type
3.3.3.6.2 Rest of Europe Anti-Tumor Drugs Market, By Application
3.4. Asia-Pacific
3.4.1 Asia-Pacific Anti-Tumor Drugs Market, By Type
3.4.2 Asia-Pacific Anti-Tumor Drugs Market, By Application
3.4.3 Asia-Pacific Anti-Tumor Drugs Market, By Country
3.4.3.1 China
3.4.3.1.1 China Anti-Tumor Drugs Market, By Type
3.4.3.1.2 China Anti-Tumor Drugs Market, By Application
3.4.3.2 India
3.4.3.2.1 India Anti-Tumor Drugs Market, By Type
3.4.3.2.2 India Anti-Tumor Drugs Market, By Application
3.4.3.3 Japan
3.4.3.3.1 Japan Anti-Tumor Drugs Market, By Type
3.4.3.3.2 Japan Anti-Tumor Drugs Market, By Application
3.4.3.4 Australia
3.4.3.4.1 Australia Anti-Tumor Drugs Market, By Type
3.4.3.4.2 Australia Anti-Tumor Drugs Market, By Application
3.4.3.5 South Korea
3.4.3.5.1 South Korea Anti-Tumor Drugs Market, By Type
3.4.3.5.2 South Korea Anti-Tumor Drugs Market, By Application
3.4.3.6 Rest of Asia
3.4.3.6.1 Rest of Asia Anti-Tumor Drugs Market, By Type
3.4.3.6.2 Rest of Asia Anti-Tumor Drugs Market, By Application
3.5. Rest of World
3.5.1 Rest of World Anti-Tumor Drugs Market, By Type
3.5.2 Rest of World Anti-Tumor Drugs Market, By Application
3.5.3 Rest of World Anti-Tumor Drugs Market, By Country
3.5.3.1 Brazil
3.5.3.1.1 Brazil Anti-Tumor Drugs Market, By Type
3.5.3.1.2 Brazil Anti-Tumor Drugs Market, By Application
3.5.3.2 South Africa
3.5.3.2.1 South Africa Anti-Tumor Drugs Market, By Type
3.5.3.2.2 South Africa Anti-Tumor Drugs Market, By Application
3.5.3.3 GCC
3.5.3.3.1 GCC Anti-Tumor Drugs Market, By Type
3.5.3.3.2 GCC Anti-Tumor Drugs Market, By Application
3.5.3.4 RoW Countries
3.5.3.4.1 RoW Countries Anti-Tumor Drugs Market, By Type
3.5.3.4.2 RoW Countries Anti-Tumor Drugs Market, By Application
RoW Countries Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD LIST OF TABLES
TABLE 1. Global Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD
TABLE 2. Chemotherapy Market Value, By Region, 2020-2029, Million USD
TABLE 3. North America Chemotherapy Market Value, By Country, 2020-2029, Million USD
TABLE 4. Europe Chemotherapy Market Value, By Country, 2020-2029, Million USD
TABLE 5. Asia-Pacific Chemotherapy Market Value, By Country, 2020-2029, Million USD
TABLE 6. Rest of World Chemotherapy Market Value, By Country, 2020-2029, Million USD
TABLE 7. Hormonal Therapy Market Value, By Region, 2020-2029, Million USD
TABLE 8. North America Hormonal Therapy Market Value, By Country, 2020-2029, Million USD
TABLE 9. Europe Hormonal Therapy Market Value, By Country, 2020-2029, Million USD
TABLE 10. Asia-Pacific Hormonal Therapy Market Value, By Country, 2020-2029, Million USD
TABLE 11. Rest of World Hormonal Therapy Market Value, By Country, 2020-2029, Million USD
TABLE 12. Immunotherapy Market Value, By Region, 2020-2029, Million USD
TABLE 13. North America Immunotherapy Market Value, By Country, 2020-2029, Million USD
TABLE 14. Europe Immunotherapy Market Value, By Country, 2020-2029, Million USD
TABLE 15. Asia-Pacific Immunotherapy Market Value, By Country, 2020-2029, Million USD
TABLE 16. Rest of World Immunotherapy Market Value, By Country, 2020-2029, Million USD
TABLE 17. Other Types Market Value, By Region, 2020-2029, Million USD
TABLE 18. North America Other Types Market Value, By Country, 2020-2029, Million USD
TABLE 19. Europe Other Types Market Value, By Country, 2020-2029, Million USD
TABLE 20. Asia-Pacific Other Types Market Value, By Country, 2020-2029, Million USD
TABLE 21. Rest of World Other Types Market Value, By Country, 2020-2029, Million USD
TABLE 22. Global Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD
TABLE 23. Lung Cancer Market Value, By Region, 2020-2029, Million USD
TABLE 24. North America Lung Cancer Market Value, By Country, 2020-2029, Million USD
TABLE 25. Europe Lung Cancer Market Value, By Country, 2020-2029, Million USD
TABLE 26. Asia-Pacific Lung Cancer Market Value, By Country, 2020-2029, Million USD
TABLE 27. Rest of World Lung Cancer Market Value, By Country, 2020-2029, Million USD
TABLE 28. Other Applications Market Value, By Region, 2020-2029, Million USD
TABLE 29. North America Other Applications Market Value, By Country, 2020-2029, Million USD
TABLE 30. Europe Other Applications Market Value, By Country, 2020-2029, Million USD
TABLE 31. Asia-Pacific Other Applications Market Value, By Country, 2020-2029, Million USD
TABLE 32. Rest of World Other Applications Market Value, By Country, 2020-2029, Million USD
TABLE 33. Stomach Cancer Market Value, By Region, 2020-2029, Million USD
TABLE 34. North America Stomach Cancer Market Value, By Country, 2020-2029, Million USD
TABLE 35. Europe Stomach Cancer Market Value, By Country, 2020-2029, Million USD
TABLE 36. Asia-Pacific Stomach Cancer Market Value, By Country, 2020-2029, Million USD
TABLE 37. Rest of World Stomach Cancer Market Value, By Country, 2020-2029, Million USD
TABLE 38. Breast Cancer Market Value, By Region, 2020-2029, Million USD
TABLE 39. North America Breast Cancer Market Value, By Country, 2020-2029, Million USD
TABLE 40. Europe Breast Cancer Market Value, By Country, 2020-2029, Million USD
TABLE 41. Asia-Pacific Breast Cancer Market Value, By Country, 2020-2029, Million USD
TABLE 42. Rest of World Breast Cancer Market Value, By Country, 2020-2029, Million USD
TABLE 43. Global Anti-Tumor Drugs Market Value, By Region, 2020-2029, Million USD
TABLE 44. North America Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD
TABLE 45. North America Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD
TABLE 46. North America Anti-Tumor Drugs Market Value, By Country, 2020-2029, Million USD
TABLE 47. U.S. Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD
TABLE 48. U.S. Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD
TABLE 49. Canada Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD
TABLE 50. Canada Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD
TABLE 51. Mexico Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD
TABLE 52. Mexico Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD
TABLE 53. Europe Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD
TABLE 54. Europe Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD
TABLE 55. Europe Anti-Tumor Drugs Market Value, By Country, 2020-2029, Million USD
TABLE 56. Germany Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD
TABLE 57. Germany Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD
TABLE 58. France Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD
TABLE 59. France Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD
TABLE 60. U.K. Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD
TABLE 61. U.K. Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD
TABLE 62. Italy Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD
TABLE 63. Italy Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD
TABLE 64. Spain Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD
TABLE 65. Spain Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD
TABLE 66. Rest of Europe Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD
TABLE 67. Rest of Europe Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD
TABLE 68. Asia-Pacific Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD
TABLE 69. Asia-Pacific Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD
TABLE 70. Asia-Pacific Anti-Tumor Drugs Market Value, By Country, 2020-2029, Million USD
TABLE 71. China Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD
TABLE 72. China Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD
TABLE 73. India Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD
TABLE 74. India Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD
TABLE 75. Japan Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD
TABLE 76. Japan Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD
TABLE 77. Australia Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD
TABLE 78. Australia Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD
TABLE 79. South Korea Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD
TABLE 80. South Korea Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD
TABLE 81. Rest of Asia Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD
TABLE 82. Rest of Asia Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD
TABLE 83. Rest of World Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD
TABLE 84. Rest of World Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD
TABLE 85. Rest of World Anti-Tumor Drugs Market Value, By Country, 2020-2029, Million USD
TABLE 86. Brazil Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD
TABLE 87. Brazil Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD
TABLE 88. South Africa Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD
TABLE 89. South Africa Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD
TABLE 90. GCC Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD
TABLE 91. GCC Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD
TABLE 92. RoW Countries Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD
TABLE 93. RoW Countries Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD
RoW Countries Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us